Recent advances in treatment of follicular lymphoma: efficacy of PI3Kα/δ inhibitor (TQ-B3525)

Signal Transduct Target Ther. 2024 May 16;9(1):134. doi: 10.1038/s41392-024-01842-z.
No abstract available

Publication types

  • Letter

MeSH terms

  • Class I Phosphatidylinositol 3-Kinases* / antagonists & inhibitors
  • Class I Phosphatidylinositol 3-Kinases* / genetics
  • Humans
  • Lymphoma, Follicular* / drug therapy
  • Lymphoma, Follicular* / genetics
  • Phosphoinositide-3 Kinase Inhibitors* / pharmacology
  • Phosphoinositide-3 Kinase Inhibitors* / therapeutic use

Substances

  • PIK3CD protein, human
  • PIK3CA protein, human